As the U.S. stock market grapples with political and economic uncertainty, leading to a correction in major indices like the S&P 500 and Nasdaq Composite, investors are increasingly seeking stability ...
H.C. Wainwright analyst Yi Chen raised the firm’s price target on LifeMD (LFMD) to $14 from $12 and keeps a Buy rating on the shares. The ...
Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good afternoon. Thank you for joining us to discuss LifeMD, Inc.
SciSparc Ltd. SPRC shares fell 18.1% to $0.3278 in pre-market trading. SciSparc shares gained around 27% on Monday after ...
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 million ...
LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid ...
Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...
Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation ...
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 ...
LifeMD reported a fourth-quarter loss per share of 2 cents. Analysts were expecting a loss of 5 cents per share, according to FactSet. Revenue for the fourth quarter came in at $64.3 million. Analysts ...
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results